Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children

被引：2
|
作者：
Funk, M
Linde, R
Braner, HJ
Groeschel, B
Kornhuber, B
Kreuz, W
机构：
[1] Univ Frankfurt Klinikum, Dept Paediat, D-60590 Frankfurt, Germany
[2] Univ Frankfurt Klinikum, Dept Virol, D-60590 Frankfurt, Germany
来源：
EUROPEAN JOURNAL OF PEDIATRICS | 1999年 / 158卷 / 01期
关键词：
D O I：
10.1007/s004310051021
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [1] Genotypic and phenotypic resistance under zidovudine and lamivudine therapy in human immunodeficiency virus-infected children
    M. Funk
    R. Linde
    H. J. Braner
    B. Groeschel
    B. Kornhuber
    W. Kreuz
    [J]. European Journal of Pediatrics, 1999, 158 : 86 - 87
  • [2] ZIDOVUDINE THERAPY IN THROMBOCYTOPENIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
    LAMBERT, G
    ARPADI, S
    WIZNIA, A
    WONG, M
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (11) : 875 - 875
  • [3] Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals
    Rodriguez, JF
    Rodriguez, JL
    Santana, J
    García, H
    Rosario, O
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3097 - 3100
  • [4] MYOPATHY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN RECEIVING LONG-TERM ZIDOVUDINE THERAPY
    WALTER, EB
    DRUCKER, RP
    MCKINNEY, RE
    WILFERT, CM
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (01): : 152 - 155
  • [5] Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus ribonucleic acid in children and adolescents infected with human immunodeficiency virus
    Solder, B
    Wintergerst, U
    Notheis, G
    Eberle, J
    Gurtler, L
    Belohradsky, BH
    [J]. JOURNAL OF PEDIATRICS, 1997, 130 (02): : 293 - 299
  • [6] Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine
    Picard, V
    Angelini, E
    Maillard, A
    Race, E
    Clavel, F
    Chêne, G
    Ferchal, F
    Molina, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06): : 781 - 784
  • [7] Zidovudine therapy and left ventricular function and mass in human immunodeficiency virus-infected patients
    Cardoso, JS
    Moura, B
    MotaMiranda, A
    Goncalves, FR
    Lecour, H
    [J]. CARDIOLOGY, 1997, 88 (01) : 26 - 28
  • [8] Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine
    Montaner, JSG
    Mo, T
    Raboud, JM
    Rae, S
    Alexander, CS
    Zala, C
    Rouleau, D
    Harrigan, PR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02): : 729 - 732
  • [9] DEVELOPMENT AND SIGNIFICANCE OF ZIDOVUDINE RESISTANCE IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    OGINO, MT
    DANKNER, WM
    SPECTOR, SA
    [J]. JOURNAL OF PEDIATRICS, 1993, 123 (01): : 1 - 8
  • [10] Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients
    Cato, A
    Qian, J
    Hsu, A
    Levy, B
    Leonard, J
    Granneman, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1788 - 1793
12345